Project Number 5R01AG057684-05 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for In Silico Screening of Medications for Slowing Alzheimer's Disease Progression. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development b. Translational Bioinformatics and Multi-scale Modeling Researcher and Organization Principal Investigator KENNEDY, RICHARD E Principal Investigator First Name RICHARD E Principal Investigator Last Name KENNEDY Awardee Organization UNIVERSITY OF ALABAMA BIRMINGHAM Awardee State Alabama Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $645,978 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
